NextFin News -- BioMap, a life science AI startup backed by Chinese tech giant Baidu, has reportedly filed a confidential application for an initial public offering (IPO) to the Hong Kong Stock Exchange. BioMap, founded and led by Baidu's founder Robin Li, aims to raise several hundred million dollars. In June 2025, BioMap's CEO Liu Wei said that the company plans to pursue a public listing in Hong Kong within approximately the next year and a half.